A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Alkylating
  • Ifosfamide
  • Sarcoma, Synovial

abstract

  • Size and location govern prognosis in primary synovial sarcoma resected with curative intent. A nomogram based on preoperative variables provides individualized patient survival estimates and shows an early survival benefit to chemotherapy that may dissipate over time. This nomogram may improve decision-making with regards to selecting patients most likely to benefit from neoadjuvant/adjuvant chemotherapy.

publication date

  • December 15, 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2779709

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-08-0843

PubMed ID

  • 19088035

Additional Document Info

start page

  • 8191

end page

  • 7

volume

  • 14

number

  • 24